Quarterly report pursuant to Section 13 or 15(d)

Supplemental Disclosure of Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details)

v3.19.3.a.u2
Supplemental Disclosure of Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash paid for interest $ 303,208
Cash paid for income taxes 45,000 20,000
Exchange of Series I-2 Preferred Stock for common stock 1,143,974 633,101
Cashless exercise of warrants 11,961 4,619,150
Debentures converted into common stock 8,085,342
Common stock issued in cashless exercise of warrants 11,961
Exchange of debentures for Series I-2 preferred stock 1,420
Conversions of Series H preferred stock into common stock 50,000
Original issue discount of debentures 400,000 1,920,000
Deemed dividend for trigger of down round provision features 123,861,587 17,942,578
Issuance of Series J Preferred Stock in settlement of note payable to related party 250,000
Acquisitions of Hospitals and Medical Center [Member]    
Cash 375
Inventory 317,427 450,682
Prepaid expenses and other current assets 310,385
Property and equipment 500,000 7,129,484
Intangible assets 250,000 504,806
Accrued expenses $ 158,890 $ 193,966